Analystreport

PDS Biotechnology Co. (NASDAQ: PDSB) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $12.00 price target on the stock.

PDS Biotechnology Corporation  (PDSB) 
Last pds biotechnology corporation earnings: 11/7 06:00 am Check Earnings Report